Join us for a complimentary webinar tailored to Pharmaceutical and Medical Device Manufacturers, followed by Live Q&A!
- OIG, DOJ & PhRMA Code Speaker Program Changes and its Impact
- Speaker Program Operational Best Practices
- Speaker Program Risk Management Tools including Auditing & Monitoring
Learn about the Operational Best Practices adapted by Pharma companies to mitigate the impact of the OIG Special Fraud Alert in light of Federal, State, and local transparency and marketing requirements in a Two-Part Webinar Series, inviting Attorneys, Event Managers, Solution Providers, Speaker Program Monitors, and Industry Experts.
25 years of experience in the pharmaceutical industry. Formerly with Wyeth, Eisai and Otsuka
Director, Transparency Reporting
Experienced Internal Auditor Formerly with Hologic
Experienced Compliance Professional within the Pharmaceutical industry Formerly with Amgen and Amylin Pharmaceuticals
Senior Director, Corporate Compliance Programs
Blue Earth Diagnostics
20+ years experience in Pharmaceutical Industry. Formerly with Bristol Myers Squibb
Heidi Kocher Esq.
20 years of experience in Healthcare Legal & Compliance